So long, reading glasses? New Raindrop eye implant could make them obsolete
16 September 2016
Thanks to a new eye implant called the Raindrop, a five-minute procedure could make reading glasses a thing of the past. NBC News medical contributor Dr. John Torres reports on the first patient to undergo the procedure since it received FDA approval.
Pfizer goes local with Russian joint venture - Doing Business With Russia
12 September 2016
The American pharmaceutical corporation is building a new facility south of Moscow to capitalize on support from government initiatives, which is also indicative of its commitment to the local market.
Pfizer goes local with Russian joint venture
07 September 2016
In July 2016, the U.S. pharmaceutical giant Pfizer became the first foreign company in its sector to localize its business in Russia with a Russian partner. Pfizer and the Russian-American company NovaMedica, whose shareholders include the Russian state-owned company Rusnano, decided to jointly invest in the construction of a plant in the Kaluga Region, 125 miles southwest of Moscow.
FDA-Approved Raindrop Near Vision Inlay Corrects Blurry Reading Vision -- Now Available in Utah for the First Time
01 September 2016
Most people begin to notice a decline in their near vision in their early 40s and 50s, which typically occurs as a result of a frustrating but inevitable age-related change in vision called presbyopia. Fortunately, recent advancements in technology provide surgical options to improve near vision and offer patients restored visual independence. On June 29, 2016, The U.S. Food and Drug Administration (FDA) approved the Raindrop® Near Vision Inlay -- a surgical implant produced by ReVision Optics, Inc. -- used to help improve near vision in patients between the ages of 45-65 years old who suffer from presbyopia.
Jeffrey Whitman, M.D., Will Be the First Dallas Eye Doctor to Implant Commercial Raindrop® Near Vision Inlays in U.S.
23 August 2016
Following extensive clinical trials, the Food and Drug Administration (FDA) approved the Raindrop Near Vision Inlay, a tiny, clear, implantable medical device, to improve near vision in some patients with presbyopia. FDA approval was granted June 29, 2016.
Follow the Money: US Companies Shrug Off Politics and Invest in Russia
11 August 2016
In spite of the US government's best efforts to sanction the Russian economy, many US companies are continuing or even increasing their investment in Russia, wrote Forbes columnist Kenneth Rapoza.
American Companies Thriving In Russia: Is There Something To Be Ashamed About?
05 August 2016
Ever since the Democratic National Committee decided to turn their disdain for Bernie Sanders into disdain for Russians and Donald Trump, the New York billionaire has been seen as being in bed with Russian oligarchs and longing to cut deals in Moscow. Since when was it so bad to want to do business with the Russians?
Will Liquid Biopsies Transform Oncology Clinical Trials?
01 August 2016
Epic Sciences says it has developed a technology that CEO Murali Prahalad believes will transform oncology trials by identifying and characterizing circulating tumor cells. Those cells have been long recognized as a key part of cancer metastasis. Tumors shed these cells into the circulatory system where they then travel to different parts of the body and, under the right conditions, become the genesis of new tumors.
Pfizer Partners with NovaMedica to Build Manufacturing Unit in Russia
20 July 2016
Pfizer Inc. (NYSE: PFE) is currently in the process of developing several manufacturing units in a number of geographical territories all over the world. Just recently, the pharmaceutical giant inked its third major deal in the in the past couple of years. This huge deal involves a partnership with NovaMedica of Russia to establish a manufacturing facility in the country.
Pfizer agrees to license 30 products to Russian pharma company
19 July 2016
US drugs company Pfizer has entered into a manufacturing and licensing agreement with Russian pharmaceutical company NovaMedica. Pfizer has proposed to invest in NovaMedica’s construction of a new manufacturing plant in the Kaluga region.
NovaMedica will produce migraine drug Relonova in Moscow
23 March 2023
A resource for anti-tumor drugs testing has been launched in Russia
23 March 2023
Building a Community of Trust in Epilepsy & Rare Syndromes
23 March 2023
Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for Ganaxolone in the Treatment of Lennox-Gastaut Syndrome
22 March 2023